【24h】

Probiotic Partial Baths for atopic Dermatitis

机译:适用于特应性皮炎的益生菌部分浴

获取原文
获取原文并翻译 | 示例
           

摘要

Background The importance of the skin microbiome in the pathogenesis of atopic dermatitis (AD) is gaining increasing attention in current research and offers opportunities for new innovative treatment options. Objectives This study investigated the efficacy of a probiotic bath additive on clinical symptoms and skin microbiome of patients with AD. Materials and methods The study was randomized and double-blind: 22 patients applied a 10-min partial bath with 4.5 x 10(9) or 9 x 10(9) colony-forming units (CFU) of viable lactic acid bacteria per liter daily over a period of 14 days. The clinical symptoms were documented using the SCORing Atopic Dermatitis (SCORAD) index and a patient questionnaire at day 0, day 7 and day 14. In addition, skin swabs were taken for subsequent nucleic acid extraction for quantitative Staphylococcus aureus polymerase chain reaction and microbiome analysis using amplicon sequencing. Results Comparable efficacy was documented in both treatment groups: Probiotic baths with a concentration of 4.5-9 x 10(9) CFU/liter led to a significant reduction in SCORAD scores (start of study: 63.04) and local SCORAD (14.68) on day 7 (SCORAD 47.09, local SCORAD 10.99) and day 14 (SCORAD 35.26, local SCORAD 8.54). Furthermore, the patient-assessed parameters skin dryness and itching improved significantly over the treatment period. At the same time, the mean gene copy number of S. aureus decreased by about 83% and microbiome analyses showed an increase in the richness of the bacterial community. Conclusions Topical application of a probiotic bath represents a promising supportive treatment option for AD that alleviates existing dysbiosis.
机译:背景皮肤微生物组在特应性皮炎(AD)发病机制中的重要性在当前的研究中越来越受到重视,并为新的创新治疗方案提供了机会。目的本研究调查益生菌沐浴添加剂对AD患者临床症状和皮肤微生物群的疗效。材料和方法本研究采用随机双盲法:22名患者在为期14天的时间内,每天用每升4.5×10(9)或9×10(9)个活乳酸菌集落形成单位(CFU)进行10分钟的部分沐浴。在第0天、第7天和第14天,使用评分特应性皮炎(SCORAD)指数和患者问卷记录临床症状。此外,取皮肤拭子进行后续核酸提取,以进行定量金黄色葡萄球菌聚合酶链反应,并使用扩增子测序进行微生物组分析。结果两个治疗组均记录了相似的疗效:浓度为4.5-9 x 10(9)CFU/升的益生菌浴导致第7天(SCORAD 47.09,局部SCORAD 10.99)和第14天(SCORAD 35.26,局部SCORAD 8.54)的SCORAD评分(研究开始:63.04)和局部SCORAD(14.68)显著降低。此外,患者评估参数皮肤干燥和瘙痒在治疗期间显著改善。同时,金黄色葡萄球菌的平均基因拷贝数减少了约83%,微生物组分析显示细菌群落的丰富度增加。结论局部应用益生菌浴是一种很有希望的AD支持性治疗选择,可以缓解现有的生态失调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号